S&P 500Dow JonesNASDAQ 100DAX 40MDAXSDAXTecDAXATXSMICAC 40AEXBEL 20IBEX 35
Home/S&P 500/ResMed
ResMed

ResMed

RMDS&P 500
222,74 $
Dividend yield0,85 %
Continuity15 yr
Dividend1,86 $
DiviScore
77SCOREExcellent
Performance33/35
Dividend Quality23/35
AGM Date
Ex-Date
20.08.2026
Payment
CAGR 3Y
+13.6%
CAGR 5Y
-5.9%
CAGR 10Y
+12.8%

€10,000 invested in 2016 · with dividend reinvestment

+272%
End Value
37.209,23 $
Total Return
+272.1%
Annual Return
14.0% p.a.
Dividends Received
2.749,01 $

Dividend history

15 years continuous
YearAmountDividend yieldAGM dateEx-datePayment dateChange
20261,86 $20.08.2026-17.7%
20252,26 $13.11.2025+326.4%
20240,53 $07.11.2024-71.2%
20231,84 $08.11.2023+7.0%
20221,72 $09.11.2022+6.2%
20211,62 $09.11.2021+3.8%
20201,56 $10.11.2020+2.6%
20191,52 $06.11.2019+5.6%
20181,44 $07.11.2018+5.9%
20171,36 $08.11.2017+7.9%

Quarterly Results

86% Beat Rate
QuarterDateEPS (Est.)EPS (Actual)Surprise
Q3 202606.08.20262,89 $2,95 $+2.1%
Q2 202630.04.20262,80 $2,86 $+2.1%
Q1 202629.01.20262,72 $2,81 $+3.3%
Q4 202527.10.20250,54 $0,54 $
Q3 202531.07.20252,48 $2,55 $+2.8%
Q2 202523.04.20252,36 $2,37 $+0.4%
Q1 202530.01.20252,31 $2,43 $+5.2%
Q4 202424.10.20242,04 $2,20 $+7.8%

About ResMed

ResMed is a medical device company focused on treating sleep apnea and respiratory conditions, best known for its CPAP machines and masks, backed by a growing software business that manages patients and connected devices. Recurring sales of masks and supplies, plus a large installed base, give it durable, high-margin revenue in a market with long-term demographic tailwinds. ResMed has increased its dividend for well over a decade, supported by steady cash generation from its consumables and device sales. The yield is low because the shares carry a growth premium and the company reinvests heavily in research and software, so the appeal is a reliably rising payout attached to a structurally growing healthcare business rather than high current income.

Frequently Asked Questions

The next payment date is not yet announced.
ResMed has a DiviScore of 77/100. DiviScore rates dividend stocks based on price performance, dividend quality, fundamentals, and stability.
ResMed's current dividend yield is 0.85% based on the latest dividend.
ResMed (RMD) is a member of S&P 500. Current data including price, dividend, and DiviScore is updated daily.
DiviScore is a proprietary 100-point rating based on four pillars: Performance (35 pts), Dividend Quality (35 pts), Fundamentals (15 pts), and Stability (15 pts). It simulates a 10-year investment with automatic dividend reinvestment.